# Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/bevacizumab-for-newly-diagnosed-pleural-mesothelioma-in-the-mesothelioma-avastin/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Gérard Zalcman,Julien Mazières,J. Margery,Laurent Greillier,Clarisse Audigier-Valette,Denis Moro‐Sibilot,Olivier Molinier,R. Corre,I. Monnet,V. Gounant,F. Rivière,Henri Janicot,Radj Gervais,Chrystèle Locher,B. Milleron,Quan Le Tran,Marie-Paule Lebitasy,Franck Morin,Christian Créveuil,Jean‐Jacques Parienti,Arnaud Scherpereel |
| Citations | 975 |
| DOI | 10.1016/s0140-6736(15)01238-6 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2215044613 |
| PMID | 26719230 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Denis Moro‐Sibilot](https://scholariq.org/researchers/denis-moro-sibilot/)
- [Julien Mazières](https://scholariq.org/researchers/julien-mazieres/)
- [V. Gounant](https://scholariq.org/researchers/v-gounant/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Occupational and environmental lung diseases](https://scholariq.org/topics/occupational-and-environmental-lung-diseases/)

## Paper topics

- [Occupational and environmental lung diseases](https://scholariq.org/topics/occupational-and-environmental-lung-diseases/)
- [Pleural and Pulmonary Diseases](https://scholariq.org/topics/pleural-and-pulmonary-diseases/)
- [Cancer Research and Treatments](https://scholariq.org/topics/cancer-research-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.